Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,254 across all filing types
Latest filing 2013-08-19 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
第一届监事会第十四次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of resolutions passed at the 14th meeting of the Supervisory Board of SanNuo Biological Sensor Co., Ltd. It details the approval of proposals related to the management of surplus raised funds and the use of idle funds for low-risk financial products. The document includes voting results and confirms compliance with company law and articles of association. It does not contain financial statements, audit opinions, or detailed financial data. It is not a full report but an announcement of board decisions. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2013-08-19 Chinese
中信证券股份有限公司关于公司将部分超募资金转存为定期存款的核查意见
Capital/Financing Update Classification · 95% confidence The document is a due diligence opinion from CITIC Securities regarding the transfer of part of over-raised funds by SanNuo Bio-sensing Co., Ltd. into fixed-term deposits. It references regulatory rules related to securities issuance and listing, and it is a verification report by the sponsor on the use of IPO proceeds. The document is short (1138 characters) and does not contain financial statements or detailed financial data. It is not an annual or interim report, nor an earnings release or management discussion. It is a specific verification opinion related to capital use post-IPO, which fits best under Capital/Financing Update (CAP) as it concerns the handling of raised capital funds and their placement. It is not a general regulatory filing or announcement of a report, but a substantive sponsor opinion on capital use.
2013-08-19 Chinese
关于将部分超募资金转存为定期存款的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by SanNuo Biological Sensor Co., Ltd. regarding the transfer of part of the over-raised funds from a current deposit to a fixed-term deposit. It details the amount of funds raised, the approval by the board, the bank details, interest rates, and management commitments related to the funds. The document is short (1341 characters) and focuses on a specific capital management action rather than a full financial report or earnings release. It does not contain financial statements or comprehensive financial data. This fits the definition of a Capital/Financing Update (CAP), as it updates on the company's fundraising and capital management activities.
2013-08-19 Chinese
中信证券股份有限公司关于公司利用自有闲置资金择机购买低风险银行理财产品、资产管理计划及信托产品的核查意见
Regulatory Filings Classification · 95% confidence The document is a due diligence and verification opinion from CITIC Securities regarding the company's use of idle funds to purchase low-risk financial products. It is a formal opinion related to the company's financial management practices and investment risk controls, not a financial report or earnings release. The document references regulatory rules and internal controls but does not contain financial statements or earnings data. It is a specialized regulatory or compliance filing related to investment activities and risk management, typical of a Regulatory Filings (RNS) category. The document length is short (2426 characters), and it is not an announcement of a report publication but a standalone verification opinion.
2013-08-19 Chinese
独立董事对相关事项的独立意见
Regulatory Filings Classification · 95% confidence The document is an independent directors' opinion on specific company matters related to the use of surplus funds and investment in low-risk financial products. It references compliance with regulatory guidelines and provides formal approval opinions. The document is short (1112 characters) and does not contain financial statements or detailed financial data. It is not an annual or interim report, nor an earnings release. It is also not a certification or a voting result announcement. The content fits best with a Regulatory Filing (RNS) as it is a formal regulatory compliance document expressing independent directors' opinions on financial matters, without constituting a full report or announcement of a report.
2013-08-19 Chinese
关于使用自有闲置资金购买低风险理财产品的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by the company 三诺生物传感股份有限公司 regarding the use of its own idle funds to purchase low-risk financial products. It details the investment purpose, amount, types of products, risk analysis, and approvals by the board, supervisory committee, independent directors, and the sponsoring institution. The document is a formal disclosure about a financing or capital management activity, specifically about the company's use of funds for investment purposes. It is not a financial report, earnings release, or management discussion. It is not a regulatory certification or a voting result announcement. The content fits best under Capital/Financing Update (CAP) as it relates to the company's capital usage and investment activities with its own funds.
2013-08-19 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.